Vedam L. Ramprasad

Medgenome Labs Pvt Ltd. operates as genomics-based diagnostics and research company. It delivers health care by decoding genetic information contained in an individual’s genome. The firm’s solutions apply cutting-edge genomics technologies, bioinformatics, computing, big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases. The company was founded by Sam Santhosh in 2013 and is headquartered in Bangalore, India.

Medgenome Labs Pvt Ltd. operates as genomics-based diagnostics and research company. It delivers health care by decoding genetic information contained in an individual’s genome. The firm’s solutions apply cutting-edge genomics technologies, bioinformatics, computing, big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases. The company was founded by Sam Santhosh in 2013 and is headquartered in Bangalore, India.

Medgenome Labs Pvt Ltd. operates as genomics-based diagnostics and research company. It delivers health care by decoding genetic information contained in an individual’s genome. The firm’s solutions apply cutting-edge genomics technologies, bioinformatics, computing, big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases. The company was founded by Sam Santhosh in 2013 and is headquartered in Bangalore, India.

Medgenome Labs Pvt Ltd. operates as genomics-based diagnostics and research company. It delivers health care by decoding genetic information contained in an individual’s genome. The firm’s solutions apply cutting-edge genomics technologies, bioinformatics, computing, big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases. The company was founded by Sam Santhosh in 2013 and is headquartered in Bangalore, India.

Medgenome Labs Pvt Ltd. operates as genomics-based diagnostics and research company. It delivers health care by decoding genetic information contained in an individual’s genome. The firm’s solutions apply cutting-edge genomics technologies, bioinformatics, computing, big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases. The company was founded by Sam Santhosh in 2013 and is headquartered in Bangalore, India.